Orlistat
A Proof of Concept Trial in Overweight and Obese Patients, Investigating Effect of EMP16-02 on Body Weight (Primary)
Empros Pharma AB · Phase 1/2 · Completed · Enrollment 156
No selected arm has a reported week for this endpoint.
A solid line connects the weeks the source reports.